Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, 801 N.E. 13th Street, Oklahoma City, OK, 73104, USA.
Robert M. Bird Health Sciences Library, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
J Community Health. 2022 Jun;47(3):563-575. doi: 10.1007/s10900-022-01079-3. Epub 2022 Feb 24.
American Indian and Alaska Native (AI/AN) persons bear a disproportionate burden of human papillomavirus (HPV)-associated cancers and face unique challenges to HPV vaccination. We undertook a systematic review to synthesize the available evidence on HPV vaccination barriers and factors among AI/AN persons in the United States. We searched fourteen bibliographic databases, four citation indexes, and six gray literature sources from July 2006 to January 2021. We did not restrict our search by study design, setting, or publication type. Two reviewers independently screened the titles and abstracts (stage 1) and full-text (stage 2) of studies for selection. Both reviewers then independently extracted data using a data extraction form and undertook quality appraisal and bias assessment using the modified Mixed Methods Appraisal Tool. We conducted thematic synthesis to generate descriptive themes. We included a total of 15 records after identifying 3017, screening 1415, retrieving 203, and assessing 41 records. A total of 21 unique barriers to HPV vaccination were reported across 15 themes at the individual (n = 12) and clinic or provider (n = 3) levels. At the individual level, the most common barriers to vaccination-safety and lack of knowledge about the HPV vaccine-were each reported in the highest number of studies (n = 9; 60%). The findings from this review signal the need to develop interventions that target AI/AN populations to increase the adoption and coverage of HPV vaccination. Failure to do so may widen disparities.
美国印第安人和阿拉斯加原住民(AI/AN)人群在人乳头瘤病毒(HPV)相关癌症方面负担过重,并且在 HPV 疫苗接种方面面临独特的挑战。我们进行了一项系统评价,以综合评估美国 AI/AN 人群中 HPV 疫苗接种障碍和相关因素的现有证据。我们从 2006 年 7 月到 2021 年 1 月,在 14 个文献数据库、4 个引文索引和 6 个灰色文献来源中进行了搜索。我们没有对研究设计、设置或出版物类型进行限制。两位评审员独立筛选研究的标题和摘要(第 1 阶段)和全文(第 2 阶段)以进行选择。然后,两位评审员使用数据提取表独立提取数据,并使用修改后的混合方法评估工具进行质量评估和偏倚评估。我们进行了主题综合分析,以生成描述性主题。在确定了 3017 项后,我们共纳入了 15 项记录,经过 1415 项筛选,检索到 203 项,评估了 41 项记录。在 15 个主题中,共报告了 21 个 HPV 疫苗接种障碍,分为个人(n=12)和诊所或提供者(n=3)两个层面。在个人层面上,疫苗安全性和缺乏对 HPV 疫苗的了解是最常见的接种障碍,在研究中均有最高数量的报道(n=9;60%)。本综述的研究结果表明,需要针对 AI/AN 人群制定干预措施,以提高 HPV 疫苗接种的采纳率和覆盖率。如果不这样做,可能会扩大差距。